| GENESCAPE Genetic Networks, LLC
97373762 21 Apr 2022 | on 06 Jun 2023
| Drug discovery services; scientific and technological services, namely... Class 042 Class 042 Computer & Software Services & Scientific Services Drug discovery services; scientific and technological services, namely scientific research and analysis in the field of target and drug optimization; scientific research screening of pharmaceuticals and biologics for therapeutic use including small molecules, proteins, RNA and DNA; scientific research screening using an entire genomes response to an administered compound or compounds; scientific research screening to find responses to therapeutic compounds by gene variants in a patient population; scientific research screening to find adverse events to therapeutic compounds and functional gene cluster mapping of interacting genes of an entire genomic response to administered compound; scientific research for medical purposes for identification of new clinical indications for known compounds; scientific research for medical purposes for comprehensive disease space mapping to understand how a compound fits into a disease space; and scientific research in the nature of comprehensive analysis of competitive drugs and derivatives thereof from a functional genome response to find new drug targets | | | GENESCAPE Genetic Networks, LLC
88697933 19 Nov 2019 | on 24 May 2021 | Drug discovery services; scientific and technological services, namely... Class 042 Class 042 Computer & Software Services & Scientific Services GENE ESCAPE | | | DO THE RIGHT THING... RIGHT! Genetic Networks, LLC
88892901 29 Apr 2020 | on 09 Feb 2021 | Drug discovery services; scientific and technological services, namely... Class 042 Class 042 Computer & Software Services & Scientific Services Drug discovery services; scientific and technological services, namely, scientific research and analysis in the field target and drug optimization; scientific research screening of pharmaceuticals and biologics for therapeutic use including small molecules, proteins, RNA and DNA; scientific research screening using an entire genomes response to an administered compound or compounds; scientific research screening to find responses to therapeutic compounds by gene variants in a patient population; scientific research screening to find adverse events to therapeutic compounds and functional gene cluster mapping of interacting genes of an entire genomic response to administered compound; scientific research for medical purposes for identification of new clinical indications for known compounds; scientific research for medical purposes for comprehensive disease space mapping to understand how a compound fits into a disease space; and scientific research and comprehensive analysis of competitive drugs and derivatives thereof from a functional genome response to find new drug targets | |